Product
BRII-296
1 clinical trial
1 indication
Indication
Postpartum DepressionClinical trial
A Phase 2a, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Descriptive Efficacy of BRII-296 in Adults With Severe Postpartum Depression (PPD)Status: Completed, Estimated PCD: 2024-03-13